Sofinnova Partners SAS, 10% Owner at Omthera Pharmaceuticals, Inc. (OMTH), sold 196 shares at $8.00 ($2K) on 2013-04-16, disclosed to the SEC on 2013-04-18.
Open-market sale of $2k OMTH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| HOOK | SELL | 2021-03-31 | $963K | — | Filing → |
| HOOK | SELL | 2021-03-29 | $749K | — | Filing → |
| HOOK | SELL | 2021-03-26 | $722K | — | Filing → |